Potential Decrease in E-cigarette Products in Louisiana due to New Regulations

Market by 2FIRSTS.ai
Oct.26.2023
Potential Decrease in E-cigarette Products in Louisiana due to New Regulations
Louisiana is considering a new law that could reduce e-cigarette products on the market due to increased regulation.

In recent news, according to KPLC television station, a new law is being considered in the state of Louisiana, USA, which aims to regulate nicotine products. As a result, it is predicted that there may be a decrease in e-cigarette products in the market.

 

A new law is set to come into effect on November 1, requiring all e-cigarette manufacturers to register their products with the Louisiana Alcohol and Tobacco Control (ATC) Commission. Without this approval, the sale of their products in the state would be illegal. Meanwhile, a list of unauthorized products will also be released on November 1.

 

The owner of the e-cigarette shop, Bilal Wardariya, stated:

 

Each store is set to reduce approximately 30% to 40% of products, which will not only impact our sales but also impact our staff salaries and expenses. These effects will be worse for our business than we imagined.

 

This legislation stems from a bill to raise taxes on e-cigarettes, which have doubled this year. However, Valladariya argues that the restrictions on e-cigarette usage are excessive.

 

I believe the ban on e-cigarettes has had negative consequences on various aspects of this state, not only for the people but also for the entire state, as we generate substantial tax revenue. Overall, I hope to see this issue resolved, and we can continue the sales and maintain the processes we have had for many years.

 

Other e-cigarette shops in the local area also believe that this will impact their business, but they believe that both the state government and consumers will also suffer the same consequences.

 

To continue selling the product, a fee of $100 per product needs to be paid, along with obtaining approval from the Air Traffic Control (ATC) and the Food and Drug Administration (FDA) in the United States.

 

Disclaimer: 
This article is translated from an original Chinese article available on 2firsts.cn by AI, and has been reviewed and edited by 2FIRSTS's English editorial team. The Chinese original text is the only authoritative source of information. The exclusive copyright and license rights to this article are held by 2FIRSTS Technology Co., Ltd. Any reproduction, reprinting, or redistribution of this article, either in part or in full, requires express written permission from 2FIRSTS and must include clear attribution along with a link to this content. Non-compliance may result in legal action. 2FIRSTS Technology Co., Ltd. reserves the right to pursue legal actions in case of unauthorized use or distribution.